Open | $4.890 |
Close | $4.940 |
Volume / Avg. | 129.813K / 215.084K |
Day Range | 4.830 - 5.020 |
52 Wk Range | 3.040 - 8.935 |
Market Cap | $242.755M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 44 |
Short Interest | 2.46% |
Days to Cover | 3.47 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Akoya Biosciences (NASDAQ: AKYA) through any online brokerage.
Other companies in Akoya Biosciences’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS), Lifecore Biomedical (NASDAQ:LFCR) and Quanterix (NASDAQ:QTRX).
The latest price target for Akoya Biosciences (NASDAQ: AKYA) was reported by JP Morgan on Wednesday, March 6, 2024. The analyst firm set a price target for 10.00 expecting AKYA to rise to within 12 months (a possible 102.43% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Akoya Biosciences (NASDAQ: AKYA) is $4.94 last updated March 18, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Akoya Biosciences.
Akoya Biosciences’s Q1 earnings are confirmed for Monday, May 6, 2024.
There is no upcoming split for Akoya Biosciences.
Akoya Biosciences is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.